No. |
Product Name |
CAS No. |
Spec |
Price |
|
1478571 |
Ondansetron (300 mg) |
99614-02-5 |
|
|
1478582 |
Ondansetron Hydrochloride (300 mg) |
103639-04-9 |
|
|
1478593 |
Ondansetron Related Compound A (50 mg) (3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride) |
119812-29-2 |
|
|
1478618 |
Ondansetron Related Compound C (30 mg) (1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one) |
27397-31-1 |
|
|
1478629 |
Ondansetron Related Compound D (30 mg) (1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one) |
N/A |
|
|
1478630 |
Ondansetron Resolution Mixture (50 mg) |
N/A |
|
|
1478673 |
Orbifloxacin (350 mg) |
113617-63-3 |
|
|
1478742 |
Ormeloxifene Hydrochloride (200 mg) |
51023-56-4 |
|
|
1478800 |
Orlistat (200 mg) |
96829-58-2 |
|
|
1478811 |
Orlistat Related Compound A (25 mg) ((3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone) |
104872-06-2 |
|
|
1478822 |
Orlistat Related Compound B (10 mg) (diisopropyl bicarbamate) |
19740-72-8 |
|
|
1478833 |
Orlistat Related Compound C (25 mg) (Triphenylphosphine oxide) |
791-28-6 |
|
|
1478844 |
Orlistat Related Compound D (10 mg) (N-formyl-L-leucine (3S,4R,6S)-3-hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-yl ester) |
130793-27-0 |
|
|
1478855 |
Orlistat Related Compound E (10 mg) (N-formyl-S-isoleucin-(S)-1-[[(2S, 3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester) |
N/A |
|
|
1479009 |
Orphenadrine Citrate (200 mg) |
4682-36-4 |
|
|
1479010 |
Orphenadrine Related Compound A (50 mg) ((RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate) (AS) |
N/A |
|
|
1479020 |
Orphenadrine Related Compound B (20 mg) (N-ethyl-N,N-dimethyl [2-(2-methylbenzhydryloxy)ethyl]ammonium chloride) |
N/A |
|
|
1479031 |
Orphenadrine Related Compound C (20 mg) (N-methyl-[2-(2-methylbenhydryloxy)ethyl]amine hydrochloride) |
10488-36-5 |
|
|
1479304 |
Oseltamivir Phosphate (200 mg) |
204255-11-8 |
|
|
1479315 |
Oseltamivir Related Compound A (10 mg) ((3S,4R,5S)-ethyl 4-acetamido-5-amino-2-azido-3-(pentan-3-yloxy)cyclohexanecarboxylate) |
N/A |
|
|